Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Peak Height and Percentage Signal Recovery for Evaluation and Determination of Pseudoprogression in Glioblastoma Patients

NCT02905643 is registered in ClinicalTrials.gov with Ascension Health as lead sponsor.

NCT NCT02905643
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02905643 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Peak Height and Percentage Signal Recovery for Evaluation and Determination of Pseudoprogression in Glioblastoma Patients
Lead sponsor
Ascension Health
Phase
Observational
Overall status
Terminated
Start date
September 30, 2016
Completion date
February 13, 2018
Enrollment
1 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

glioblastoma